Liabilities of Omega Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary: Omega Therapeutics, Inc. quarterly Liabilities in USD history and change rate from 31 Dec 2020 to 30 Sep 2024.
Omega Therapeutics, Inc. Liabilities for the quarter ending 30 Sep 2024 was $141,184,000, a 0.41% decline year-over-year.
Source SEC data: View on sec.gov

Liabilities, Quarterly (USD)

Liabilities, YoY Quarterly Change (%)

Omega Therapeutics, Inc. Quarterly Liabilities (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	$141,184,000	-$581,000	-0.41%	30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q2 2024	$141,963,000	+$8,860,000	+6.7%	30 Jun 2024	10-Q	06 Aug 2024	2024	Q2
Q1 2024	$142,326,000	+$109,011,000	+327%	31 Mar 2024	10-Q	06 May 2024	2024	Q1
Q4 2023	$146,350,000	+$106,323,000	+266%	31 Dec 2023	10-Q	14 Nov 2024	2024	Q3
Q3 2023	$141,765,000	+$105,351,000	+289%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$133,103,000	+$97,441,000	+273%	30 Jun 2023	10-Q	03 Aug 2023	2023	Q2
Q1 2023	$33,315,000	-$2,632,000	-7.3%	31 Mar 2023	10-Q	04 May 2023	2023	Q1
Q4 2022	$40,027,000	+$7,322,000	+22%	31 Dec 2022	10-K	28 Mar 2024	2023	FY
Q3 2022	$36,414,000	+$13,482,000	+59%	30 Sep 2022	10-Q	08 Nov 2022	2022	Q3
Q2 2022	$35,662,000	+$13,725,000	+63%	30 Jun 2022	10-Q	04 Aug 2022	2022	Q2
Q1 2022	$35,947,000			31 Mar 2022	10-Q	04 May 2022	2022	Q1
Q4 2021	$32,705,000	+$15,219,000	+87%	31 Dec 2021	10-K	01 Mar 2023	2022	FY
Q3 2021	$22,932,000			30 Sep 2021	10-Q	10 Nov 2021	2021	Q3
Q2 2021	$21,937,000			30 Jun 2021	10-Q	10 Sep 2021	2021	Q2
Q4 2020	$17,486,000			31 Dec 2020	10-K	10 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.